Health · Full coverage
Over 550 Treatments Compete for Inclusion in Israel’s 2027 Health Basket Expansion
How 2 Israeli newsrooms covered this story — translated into English and compared side by side.
100% center
Center 2
First reported by Walla · Jul 6, 2026
What happened
Over 550 medications and technologies are competing for inclusion in Israel’s 2027 health basket amid budget uncertainties. Key submissions include new obesity drugs, vaccines, rare disease treatments, cancer therapies, and Alzheimer’s medications. Experts warn the basket’s budget growth lags behind rising healthcare costs, risking exclusion of vital treatments.
- 01Over 550 treatments submitted for Israel’s 2027 health basket expansion review.
- 02Budget for basket expansion remains undecided, currently about 650 million shekels annually.
- 03New obesity drugs Wegovy and Mounjaro proposed for broader adult use.
- 04Alzheimer’s drugs Lecanemab and Donanemab resubmitted despite high costs.
- 05Cancer treatments include dozens of new drugs for breast, colorectal, and lung cancers.
- 06Experts call for increased budget and structural reforms to meet growing healthcare demands.
Summary translated & synthesized from the sources below by baba. Read each original for the full report.
Full coverage · 2 outlets
The same event, reported separately by each newsroom. Open a few to compare what each emphasizes — and what they leave out.
Related stories
Israel Invests Heavily in Medical Innovation but Struggles to Integrate It Locally7 days agoEuropean Drug Shortages Raise Concerns Over Potential Impact on Israel's SupplyAug 13, 2026Israeli Health Experts Advocate Preventive Care as National Strategic InvestmentJul 21, 2026Israeli Healthcare Crisis Overshadows Election Campaigns, Urges Strategic ReformAug 10, 2026Israel Reports Shorter MRI and Elective Surgery Wait Times Compared to OECD CountriesJul 14, 2026Israel Allocates Official Funding to Expand Home Hospitalization Services NationwideJul 14, 2026
